Related Experiment Video
Updated: Nov 1, 2025

Author Spotlight: Unveiling the Polyfunctionality and Heterogeneity in Immune Responses
Published on: March 8, 2024
Hemadsorption as a Treatment Option for Multisystem Inflammatory Syndrome in Children Associated With COVID-19. A
Juan Carlos Ruiz-Rodríguez1,2, Luis Chiscano-Camón1,2, Clara Palmada1,2
1Intensive Care Department, Vall d'Hebron University Hospital, Barcelona, Spain.
Insights
Multisystem Inflammatory Syndrome in Children (MIS-C) linked to COVID-19 involves severe inflammation. A hemadsorption device was used to manage the cytokine storm in affected children.
Area of Science:
- Pediatrics
- Immunology
- Infectious Diseases
Background:
- Multisystem Inflammatory Syndrome in Children (MIS-C) is a serious condition linked to COVID-19.
- MIS-C presents with hypercytokinemia, causing excessive inflammation.
- Cytokine storm is a critical aspect of severe MIS-C.
Observation:
- The study describes the application of a hemadsorption device.
- This device was utilized as a component of supportive care.
- The intervention targeted the cytokine storm in pediatric patients.
Findings:
- Hemadsorption devices can be integrated into the management of MIS-C.
- This approach addresses the hyperinflammatory state characteristic of the syndrome.
- The use of hemadsorption offers a potential strategy for supportive treatment.
Implications:
- This highlights a novel therapeutic option for severe MIS-C cases.
- Further research may explore the efficacy and outcomes of hemadsorption in pediatric critical care.
- Managing cytokine storm with devices like hemadsorbers could improve patient prognoses.
Abstract:
Multisystem Inflammatory Syndrome in Children (MIS-C) associated with COVID-19 is characterized by hypercytokinemia leading to overwhelming inflammation. We describe the use of a hemadsorption device as part of the supportive treatment for cytokine storm.
More Related Videos
Related Concept Videos
Myocarditis III: Medical Management
Nephrotic Syndrome II : Assessment and Medical Management
Myocarditis II: Clinical Features and Diagnostic Tests

